Xos, Inc. — Form 8-K Summary
Reporting date: August 9, 2022; the report was signed August 11, 2022. The filing reports material financing transactions and does not provide operating results or period-end financial statements.
Business Context and Material Financing
- Xos, Inc. entered into financing arrangements with Aljomaih Automotive Co. and YA II PN, Ltd. (Yorkville).
- The transactions create significant new debt obligations and potential dilution through conversion into common stock.
Key Financial Terms
| Financing | Principal | Interest | Maturity | Conversion Terms |
|---|---|---|---|---|
| Aljomaih convertible promissory note | $20.0 million | 10.0% annually, generally payable in common stock at maturity | August 11, 2025 | Initial conversion price of $2.3817 per share, subject to adjustment; conversion generally available beginning November 9, 2022 |
| Yorkville convertible debentures | Up to $35.0 million; $20.0 million issued August 11, 2022 and an additional $15.0 million subject to registration effectiveness | 6.0% annually; 7.5% during a registration event and 10.0% during an event of default | November 11, 2023, with a possible three-month extension | Lower of $2.4733 per share or 97% of the applicable three-day lowest daily VWAP, subject to a $0.50 floor and adjustments |
The filing does not provide revenue, net income, cash flow, cash balance, liquidity ratios, debt-to-equity ratios, or operating margins for the reporting period.
Material Changes and Potential Dilution
- The Aljomaih note and Yorkville debentures increase the Company’s financial obligations by up to $55.0 million in aggregate principal, excluding accrued interest and any additional Aljomaih financing.
- Aljomaih may purchase up to an additional $20.0 million of convertible notes by mutual consent on or before November 30, 2022, on terms to be negotiated.
- Aljomaih conversion and interest-share issuances are generally limited to 19.99% ownership or issuance, unless Nasdaq stockholder approval is obtained.
- Yorkville issuances are subject to an exchange cap of 33,199,327 shares, unless Nasdaq stockholder approval is obtained.
- The Yorkville conversion price can decline with the market price, subject to the $0.50 floor, creating potentially substantial share dilution if the stock price declines.
Liquidity, Repayment and Other Terms
- Xos may prepay the Aljomaih note on or after August 11, 2024, subject to the note terms, without penalty.
- Yorkville debentures include a company redemption right at 105% of principal plus accrued interest, subject to conditions including a three-day VWAP below the fixed conversion price.
- If specified market-price or exchange-cap triggers occur, Xos may be required to make monthly prepayments of generally $3.0 million of principal, or $4.0 million under certain conditions, plus a 5% redemption premium and accrued interest.
- Yorkville restricted advances under the existing Standby Equity Purchase Agreement until the debentures are repaid, converted, or no longer convertible, although the SEPA remains in effect subject to its terms.
Governance, Registration and Commercial Rights
- Aljomaih received the right to designate one Class I director nominee, subject to Company and board approval and other conditions, while it owns at least 5% of the outstanding common stock.
- Aljomaih received a right of first offer for future distribution of Xos products or services in specified Middle Eastern and neighboring markets. The right generally ends when Aljomaih ceases to own at least 5% or on August 9, 2025.
- Xos is required to file a resale registration statement for Aljomaih by no later than September 16, 2022, and a Yorkville resale registration statement within 30 days after execution of the registration rights agreement.
- The securities were issued in private transactions under Section 4(a)(2) of the Securities Act and were not registered at issuance.
Guidance, Outlook, Risks and Unusual Items
- The filing provides no revenue, earnings, production, cash-flow, or forward operating guidance.
- Key risks include high interest expense, near-term maturity and prepayment obligations, possible defaults, mandatory redemptions, and dilution from variable-price conversions.
- The Company’s ability to issue shares may be constrained by Nasdaq ownership and exchange-cap limitations unless stockholder approval is obtained.
- Registration delays could increase the Yorkville interest rate to 7.5% while the applicable registration event remains in effect.
- The filing does not quantify the number of shares issuable under either financing because future issuance depends on conversion timing, market prices, accrued interest, and applicable caps.
Important Facts for Investors to Verify
- Whether the additional $15.0 million Yorkville debenture tranche was issued after the required resale registration became effective.
- Whether Aljomaih exercised or completed the potential additional $20.0 million note purchase.
- The status and filing dates of the required resale registration statements.
- Current outstanding principal, accrued interest, conversions, prepayments, and shares issued under both financings.
- Whether Nasdaq stockholder approval was obtained or is required for issuances exceeding the stated ownership and exchange caps.
- Current cash balances and operating cash burn, which are not disclosed in this 8-K but are important for assessing repayment capacity.